InsiderSignal.AI

InsiderSignal.ai

CBLL - Ceribell, Inc.

Insider Sale by Parvizi Josef (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

5 days ago, Parvizi Josef, serving as Dir at Ceribell, Inc. (CBLL), sold 8,286 shares at $20.00 per share, for a total transaction value of $165,720.00. Following this transaction, Parvizi Josef now holds 2,016,365 shares of CBLL.

The trade was executed on Tuesday, February 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 19, 2026, 2 days after the trade was made.

Ceribell, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Parvizi Josef

Parvizi Josef

Dir

Josef Parvizi, MD, PhD is a Professor of Neurology and Neurological Sciences at Stanford University, where he directs the Stanford Program for Medication Resistant Epilepsies and specializes in surgical treatments for intractable focal epilepsies.[[1]](https://profiles.stanford.edu/josef-parvizi)[[2]](https://stanfordhealthcare.org/doctors/p/josef-parvizi.html) He completed his medical education at the University of Oslo Medical School (1995), earned a PhD in Neuroscience from the University of Iowa (1999), followed by an internship at Mayo Clinic (2003), neurology residency at Beth Israel Deaconess Medical Center (2006), and fellowship in clinical neurophysiology and epilepsy at UCLA (2007).[[1]](https://profiles.stanford.edu/josef-parvizi)[[2]](https://stanfordhealthcare.org/doctors/p/josef-parvizi.html) Board-certified in Neurology (2008) and Epilepsy (2016), Parvizi leads the Laboratory of Behavioral and Cognitive Neuroscience and contributes to community efforts like the Free Neurology Clinic in Menlo Park.[[1]](https://profiles.stanford.edu/josef-parvizi) Parvizi serves as Chairman and Director at Ceribell, Inc. (CBLL), a company he co-founded and for which he invented the Ceribell Rapid Response EEG system—a portable, reduced-montage EEG device for rapid bedside seizure detection in critical care settings.[[3]](https://siren.network/wp-content/uploads/2025/06/K170363-Ceribell-EEG-Device-510K.pdf)[[4]](https://ceribell.com/eeg-university/real-world-eeg-cases-using-the-ceribell-rapid-response-system/)[[5]](https://www.youtube.com/watch?v=8BF1jDniYjY) He has authored studies validating Ceribell's Brain Stethoscope function and Clarity AI for EEG monitoring, demonstrating its utility in ICUs for non-experts.[[2]](https://stanfordhealthcare.org/doctors/p/josef-parvizi.html)[[6]](https://ceribell.com/eeg-university/clarity-ai-for-24-7-eeg-monitoring-alert-manuscript-review-with-dr-josef-parvizi/) As a corporate insider, Parvizi has recently traded shares in Ceribell.[user query context]

View full insider profile →

Trade Price

$20.00

Quantity

8,286

Total Value

$165,720.00

Shares Owned

2,016,365

Trade Date

Tuesday, February 17, 2026

5 days ago

SEC Filing Date

Thursday, February 19, 2026

Filed 2 days after trade

HEALTHCAREMEDICAL DEVICES

About Ceribell, Inc.

Company Overview

No company information available
View news mentioning CBLL

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4124553

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime